Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 ...

Pfizer (PFE) stock is moving higher after beating Wall Street expectations for the second quarter and raising its full-year ...

Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...

Many viruses circulate seasonally, picking up as the weather cools in the fall and winter. So it’s true that fewer people get ...

Pfizer Inc. raised its profit forecast for the year, with the drugmaker’s ongoing cost cuts helping to make up for a lack of ...

Pfizer stock rises after a strong Q2, boosted by cost savings, pipeline progress, and an upgraded 2025 profit outlook.

Aug 5 - Pfizer (NYSE:PFE) heads into its Q2 earnings release amid growing investor caution. Analysts expect revenue around ...

Pharmaceutical major recorded a revenue jump to $14.65 billion, exceeding the market expectations. The company also raised ...

Pharmaceutical giant Pfizer (PFE) has reported financial results for this year’s second quarter that topped Wall Street forecasts. The New York City-based company announced earnings per share (EPS) of ...

Palantir Technologies soars with AI pivot, Pfizer holds steady, Caterpillar warns in contrasting earnings reports, offering investors a mix of optimism and caution in the tech, pharmaceutical, and ...

Pfizer reported a jump in second-quarter profits Tuesday behind higher sales of Covid-19 products and some other pharmaceuticals, while also benefiting from lower expenses.